MINI FUTURE LONG - ZEALAND PHARMA Stock

Certificat

DE000MB1S9D1

Market Closed - Börse Stuttgart 11:42:41 2024-06-14 EDT
6.32 EUR +3.27% Intraday chart for MINI FUTURE LONG - ZEALAND PHARMA
Current month+5.86%
1 month+5.33%
Date Price Change
24-06-14 6.32 +3.27%
24-06-13 6.12 +6.99%
24-06-12 5.72 -6.23%
24-06-11 6.1 -3.48%
24-06-10 6.32 +2.27%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 11:42 am

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying ZEALAND PHARMA A/S
Issuer Morgan Stanley
WKN MB1S9D
ISINDE000MB1S9D1
Date issued 2022-12-27
Strike 189.3 kr
Maturity Unlimited
Parity 10 : 1
Emission price 0.44
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.69
Lowest since issue 0.33

Company Profile

Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity. At the end of 2022, the Group had a portfolio of 7 products in clinical development (including 2 in phase III, 3 in phase II and 2 in phase I), and 4 products in preclinical development.
Sector
-
More about the company

Ratings for Zealand Pharma A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Zealand Pharma A/S

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
662.5 DKK
Average target price
790.9 DKK
Spread / Average Target
+19.37%
Consensus